Publications by authors named "Jamel Chargui"

Claim this Profile
E
Expression of sphingosine-1 phosphate receptor in rat renal ischemia-reperfusion injury.
Masahide Matsuyama, Kiyoaki Funao, Katsuyuki Kuratsukuri, Tomoaki Tanaka, Yutaka Kawahito, Jamel Chargui

Mol Med Rep· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of neutrophil elastase inhibitor on acute tubular necrosis after renal ischemia-reperfusion injury.
Masahide Matsuyama, Takuma Hayama, Kiyoaki Funao, Toshihide Naganuma, Yutaka Kawahito, Jamel Chargui

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of arachidonic acid in a rat renal ischemia-reperfusion injury model.
Masahide Matsuyama, Rikio Yoshimura, Kiyoaki Funao, Yutaka Kawahito, Hajime Sano, Jamel Chargui

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between peroxisome proliferator-activated receptor-γ and renal ischemia-reperfusion injury.
Masahide Matsuyama, Rikio Yoshimura, Yutaka Kawahito, Hajime Sano, Jamel Chargui

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of cysteinylLT1 receptor in human testicular cancer and growth reduction by its antagonist through apoptosis.
Masahide Matsuyama, Kiyoaki Funao, Yutaka Kawahito, Hajime Sano, Jamel Chargui

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma.
Kiyoaki Funao, Masahide Matsuyama, Yutaka Kawahito, Hajime Sano, Jamel Chargui

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of the selective cyclooxygenase (COX)-2 inhibitor etodolac prolongs cardiac allograft survival in a mouse model.
Masahide Matsuyama, Rikio Yoshimura, Taro Hase, Jamel Chargui, Norio Yoshimura

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prope tolerance to heart allografts in mice associated with persistence of donor interleukin-10-transduced stem cells.
Leila Brikci-Nigassa, Masahide Matsuyama, Taro Hase, Assia Eljaafari, Jamel Chargui

Transplantation· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells.
Jamel Chargui, Valérie Combaret, Virginie Scaglione, Isabelle Iacono, Valentine Péri

J Immunother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telmisartan inhibits human urological cancer cell growth through early apoptosis.
Masahide Matsuyama, Kiyoaki Funao, Katsuyuki Kuratsukuri, Tomoaki Tanaka, Yutaka Kawahito, Jamel Chargui

Exp Ther Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telmisartan is a potent target for prevention and treatment in human prostate cancer.
Kiyoaki Funao, Masahide Matsuyama, Yutaka Kawahito, Hajime Sano, Jamel Chargui

Oncol Rep· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
Rachel Sembeil, Kamel Sanhadji, Geneviève Vivier, Jamel Chargui, Jean-Louis Touraine

Transpl Immunol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of nonmuscle myosin heavy chain B (SMemb) in rat allogeneic kidney transplantation.
Yoshihiro Watanabe, Rikio Yoshimura, Seiji Wada, Jamel Chargui, Junichi Suzuki

Nephron· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection.
Rikio Yoshimura, Yoshihiro Watanabe, Sinji Kasai, Seiji Wada, Akira Ohyama, Jamel Chargui

Transpl Int· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis